Pricing Log in Create free account

Abivax SA Sponsored ADR (ABVX) vs Corcept Therapeutics Incorporated (CORT)

Abivax SA Sponsored ADR and Corcept Therapeutics Incorporated are both Biotechnology companies. Abivax SA Sponsored ADR and Corcept Therapeutics Incorporated are of similar size ($7.8B and $7.4B). Abivax SA Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 47.5×. Corcept Therapeutics Incorporated has the higher net margin (16.5% vs 0.00%) and the higher return on invested capital (15.0% vs 0.00%). Across the 15 metrics below, Corcept Therapeutics Incorporated leads on 13 and Abivax SA Sponsored ADR on 2.

Valuation

Metric ABVX CORT Biotechnology median
P/E n/m 47.47 10.26
P/S n/m 7.98 9.18
P/B 15.83 9.22 2.05
Price to free cash flow n/m 39.51 24.81
EV/EBITDA n/m 67.42 0.65
EV/Sales n/m 7.61 8.98
Earnings yield (7.16%) 2.11% (34.89%)
Free cash flow yield (3.35%) 2.53% (24.52%)

Profitability

Metric ABVX CORT Biotechnology median
Gross margin 0.00% 98.54% 65.16%
Operating margin 0.00% 11.51% 0.00%
Net margin 0.00% 16.54% 0.00%
Free cash flow margin 0.00% 20.20% 0.00%
Return on equity (249.78%) 21.74% (50.12%)
Return on assets (137.67%) 17.16% (45.60%)
Return on invested capital 0.00% 14.97% 0.00%

Growth

Metric ABVX CORT Biotechnology median
Revenue growth (TTM) — 30.02% 6.26%
EPS growth (last fiscal year) (80.20%) (33.33%) 29.88%
Revenue growth, 5-year CAGR — 16.56% 9.75%
Net income growth, 5-year CAGR 0.00% (1.52%) 0.00%

Health

Metric ABVX CORT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.97 3.00 4.89
Net debt to EBITDA 2.19 (8.83) 1.01

Dividend

Metric ABVX CORT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABVX CORT Biotechnology median
Market cap 7.37b 7.84b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack